
Option Care Health (OPCH) Stock
Home infusion services provider for patients outside hospitals. Here's the price, business snapshot, and what's worth knowing about Option Care Health in August 2026.
Option Care Health (OPCH) is a US-based provider of home and alternate-site infusion services, supplying complex infusion therapies and related services to patients outside traditional hospital settings. The company partners with payers, providers and pharmaceutical manufacturers to deliver treatments for chronic and acute conditions, aiming to lower costs by shifting care to lower-cost settings. Key drivers for investors to watch include the secular shift towards outpatient care, an ageing population that increases demand for infusion therapies, and contract wins with payers and drug makers. Risks include reimbursement pressure, regulatory scrutiny, operational complexity and labour shortages, which can affect margins and volumes. With a market capitalisation of about $4.58bn, Option Care’s prospects depend on successful integration of acquired businesses, margin management and negotiating favourable terms with payers. This information is educational and not personalised advice; investors should review the latest filings, financial statements and seek professional guidance before acting.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Option Care Health Inc. stock, with a target price of $36.64.
Financial Health
Option Care Health Inc is performing well with solid revenue and cash flow generation.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Why You’ll Want to Watch This Stock
Outpatient care shift
The move from hospitals to home care can lower costs and expand volume, though reimbursement and execution risks may affect outcomes.
Demographic tailwinds
An ageing population increases demand for chronic therapies delivered at home, yet demand can vary with policy and payer decisions.
Operational complexity
Success depends on supply-chain, clinical operations and payer contracts; operational missteps or labour shortages could dent margins.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.